Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome analysis of synthetic miR-155 oligo-treated mouse CD4+ T-cells

ABSTRACT: Transcriptome analysis of synthetic miR-155 oligo-treated mouse CD4+ T-cells

PROVIDER: PRJNA576892 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10315765.fastq.gz	Fastqsanger.gz
	SRR10315766.fastq.gz	Fastqsanger.gz
	SRR10315767.fastq.gz	Fastqsanger.gz
	SRR10315768.fastq.gz	Fastqsanger.gz
	SRR10315769.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Transcriptome analysis of synthetic miR-155 oligo-treated mouse CD4+ T-cells

Project description:High-density gene expression profile of 20,000+ genes for synthetic miR-155 oligo-treated mouse CD4+ T-cells using RNA deep sequencing technology.

2019-10-11 | GSE138715 | GEO

Gene profile of aged Wt, miR-155-/-, miR-146a-/- and DKO CD4+ T cells

Project description:Differential gene expression profile of CD4+ T cells from 10 months old Wt, miR-155-/-, miR-146a-/- and DKO mice spleens. Wt, miR-155-/-, miR-146a-/- and DKO mice were aged 10 months, CD4+ T cells were sorted from mice spleens for analyses.

2014-12-09 | E-GEOD-58372 | biostudies-arrayexpress

mRNA profiling of mir-155-overexpressing fibroblasts

Project description:To identify putative fibroblasts-specific targets of mir-155, we overexpressed mir-155 in lung fibroblasts by transfecting them with a synthetic pre-mir-155 or a synthetic “negative” pre-miRNA as control (miR-Neg). RNA samples were harvested at 24 and 48 hours post-transfection and 2 independent experiments were carried out.

2009-12-22 | GSE14477 | GEO

Gene profile of aged Wt, miR-155-/-, miR-146a-/- and DKO CD4+ T cells

Project description:Differential gene expression profile of CD4+ T cells from 10 months old Wt, miR-155-/-, miR-146a-/- and DKO mice spleens.

2014-12-09 | GSE58372 | GEO

Transcriptome analysis of synthetic miR-124 sponge oligo and Salmonella-treated pig PBMCs

Project description:High-density gene expression profile for synthetic miR-124 sponge oligo-treated pig PBMCs using RNA deep sequencing technology.

2021-11-24 | GSE189380 | GEO

Sequencing of tumor associated (B16f10-OVA) mir-155 Wt or deficient CD4+ and CD8+ T cells

Project description:Tumor associated CD4+ and CD8+ T cells were sorted from B16f10 OVA expressing tumors in miR-155 flox, miR-155 flox CD4Cre+, and miR-155 flox CD4Cre+ mice treated with immune checkpoint blocking (ICB) antibodies by flow sorting on CD45+CD3+CD4+ cells and CD45+ CD3+CD8+ cells. RNA was collected from these cells to perform RNA sequencing of total RNA.

2017-09-11 | GSE101690 | GEO

Gene profile of Wt and miR-155-/- Tfh cells

Project description:Differential gene expression profile of Tfh and non-Tfh cells from both Wt and miR-155-/- mice spleens. Wt and miR-155-/- mice were immunized with OVA. 8 days post immunization, CD4+CXCR+PD1+ Tfh cells and CD4+CXCR5-PD1- non Tfh cells were sorted from mice spleens for analyses.

2014-12-09 | E-GEOD-58371 | biostudies-arrayexpress

Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma [ST486]

Project description:Several studies have indicated an important role for miR-155 in the pathogenesis of B-cell lymphoma. Highly elevated levels of miR-155 were indeed observed in most B-cell lymphomas with the exception of Burkitt lymphoma (BL). However, the molecular mechanisms that underlie the oncogenic role of miR-155 in B-cell lymphoma are not well understood. To identify the miR-155 targets relevant for B-cell lymphoma, we performed RNA immunoprecipitation of Argonaute 2 in Hodgkin lymphoma (HL) cells upon miR-155 inhibition and in BL cells upon ectopic expression of miR-155. We identified 54 miR-155-specific target genes in BL cells and confirmed miR-155 targeting of DET1, NIAM, TRIM32, HOMEZ, PSIP1 and JARID2. Five of these targets are also regulated by endogenous miR-155 in HL cells. Both overexpression of miR-155 and inhibition of expression of the novel miR-155 target gene NIAM increased proliferation of BL cells. In primary B-cell lymphoma NIAM-positive cases have significant lower levels of miR-155 as compared to NIAM-negative cases, suggesting that NIAM is also regulated by miR-155 in primary B-cell lymphoma. Thus, our data indicate an oncogenic role for miR-155 in B-cell lymphoma which involves targeting the tumor suppressor NIAM.

2015-02-20 | GSE64484 | GEO

Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma [L1236]

2015-07-16 | GSE70937 | GEO

Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma [KM-H2]

2015-07-16 | GSE70938 | GEO